Compare ValGenesis's Enterprise validation lifecycle platform (VLMS) with Valiqa, the self-serve AI-native validation platform. See how they differ in how you buy, speed, scope, and Part 11 lifecycle.
ValGenesis Horizon is a full enterprise validation lifecycle platform (VLMS) for pharma and biotech, strong on deep guided execution at scale, though its own protocol generation is partial since it assembles a draft from existing templates rather than generating from scratch. Valiqa is the self-serve alternative that already covers the essentials most teams need: full AI protocol generation, Part 11 e-signatures, a hash-chained audit trail, and deviation management, all at public $149/mo pricing with a first protocol in minutes and no demo. Where ValGenesis still leads is guided electronic execution run step-by-step in-app at enterprise scale.
ValGenesis Horizon is an enterprise VLMS that assembles and manages validation protocols. It markets a Smart Validation Document Generator that can produce a draft protocol in about 90 seconds by adapting existing validation templates, then guides companies through review, execution, and e-signature.
Large pharma and biotech enterprises that want an integrated VLMS for the whole validation lifecycle, including guided e-signature execution and multi-site coordination at enterprise scale, and that have the budget and timeline for an enterprise implementation.
Valiqa is a self-serve, AI-native validation platform. It generates audit-ready IQ, OQ, PQ, DQ, PPQ, and other protocols from your equipment specifications, and adds Part 11 e-signatures, a hash-chained audit trail, deviation management, protocol versioning, and a conversational AI advisor.
Mid-market manufacturers (10-500 employees) that want audit-ready validation, from generation through e-signed and audited approval, without an enterprise sales cycle or a six-figure implementation.
Self-serve with transparent public pricing from $149/mo and an instant free trial. No demo required to start generating protocols.
Minutes to your first protocol, instead of the demo-to-implementation cycle of an enterprise VLMS rollout.
Full protocol generation, not partial template assembly: equipment-spec-first, so you give Valiqa the equipment make, model, and parameters, and it generates the protocol.
A full Part 11 lifecycle built in: e-signatures (WebAuthn), a hash-chained audit trail, deviation management, and protocol versioning, not a separate module or add-on.
Valiqa Advisor: a conversational AI agent that scopes what each asset needs and answers grounded in your own validation data.
Learns your company's document format from a single uploaded example, and covers 20+ regulations across medical devices, pharma, biotech, and food.
| Dimension | Valiqa | ValGenesis |
|---|---|---|
How you buy | Self-serve, public $149+/mo, instant free trial | Book a demo, quote-only |
Time to first protocol | Minutes | Weeks to months |
Generates protocol content | ✓ | ◐ |
Input model | Equipment specs (make/model/params) | Requirements/lifecycle |
Part 11 lifecycle (e-sig, audit trail, deviations) | ✓ | ✓ |
Guided electronic execution (run protocols step-by-step in-app) Valiqa captures executed results under Part 11 controls | ◐ | ✓ |
Scope | AI-native validation platform (generation + Part 11 lifecycle) | Full validation lifecycle suite |
Target company size | Mid-market (10-500) | Enterprise / large |
Standards coverage | 20+ across med device, pharma, biotech, food | Pharma / life sciences |
Deeper guided electronic execution at scale: operators run protocols step-by-step in-app as the live system-of-record. (Valiqa captures executed results under Part 11 controls but does not offer the full guided execution experience.)
Full enterprise VLMS breadth: multi-site coordination and established large-enterprise deployments across pharma and biotech.
Template reuse across a large existing document library, useful if you already have years of validation documentation to draw from.
Valiqa is not affiliated with ValGenesis. All trademarks belong to their respective owners. Comparison based on publicly available information as of July 2026.
We use essential cookies for authentication and security. With your consent, we also use Microsoft Clarity on our marketing pages to understand how visitors navigate the site. Learn more.